Shandong Pharmaceutical Glass Co Ltd (600529) - Total Liabilities
Based on the latest financial reports, Shandong Pharmaceutical Glass Co Ltd (600529) has total liabilities worth CN¥1.76 Billion CNY (≈ $257.58 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 600529 net assets growth trend to track the company's year-over-year net asset growth rate.
Shandong Pharmaceutical Glass Co Ltd - Total Liabilities Trend (1999–2025)
This chart illustrates how Shandong Pharmaceutical Glass Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 600529 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Shandong Pharmaceutical Glass Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Pharmaceutical Glass Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen SDG Information Co Ltd
SHE:000070
|
China | CN¥6.18 Billion |
|
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SHG:603707
|
China | CN¥3.71 Billion |
|
Suzhou GYZ Electronic Technology Co. Ltd. A
SHG:688260
|
China | CN¥1.41 Billion |
|
GS Engineering & Construction
KO:006360
|
Korea | ₩12.66 Trillion |
|
Burkhalter Holding AG
SW:BRKN
|
Switzerland | CHF324.39 Million |
|
TBO Tek Ltd
NSE:TBOTEK
|
India | Rs58.86 Billion |
|
Primaris Retail R.E. Invest. Tr. Units
TO:PMZ-UN
|
Canada | CA$2.74 Billion |
|
Poly Medicure Limited
NSE:POLYMED
|
India | Rs7.69 Billion |
Liability Composition Analysis (1999–2025)
This chart breaks down Shandong Pharmaceutical Glass Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Pharmaceutical Glass Co Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Pharmaceutical Glass Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Pharmaceutical Glass Co Ltd (1999–2025)
The table below shows the annual total liabilities of Shandong Pharmaceutical Glass Co Ltd from 1999 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.75 Billion ≈ $255.95 Million |
-17.97% |
| 2024-12-31 | CN¥2.13 Billion ≈ $312.01 Million |
+19.51% |
| 2023-12-31 | CN¥1.78 Billion ≈ $261.09 Million |
-2.10% |
| 2022-12-31 | CN¥1.82 Billion ≈ $266.70 Million |
+4.78% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.53 Million |
+27.38% |
| 2020-12-31 | CN¥1.37 Billion ≈ $199.82 Million |
+4.84% |
| 2019-12-31 | CN¥1.30 Billion ≈ $190.60 Million |
+18.62% |
| 2018-12-31 | CN¥1.10 Billion ≈ $160.67 Million |
+18.08% |
| 2017-12-31 | CN¥929.84 Million ≈ $136.07 Million |
+8.04% |
| 2016-12-31 | CN¥860.62 Million ≈ $125.94 Million |
+16.99% |
| 2015-12-31 | CN¥735.61 Million ≈ $107.64 Million |
+6.22% |
| 2014-12-31 | CN¥692.56 Million ≈ $101.34 Million |
+2.53% |
| 2013-12-31 | CN¥675.48 Million ≈ $98.84 Million |
+0.55% |
| 2012-12-31 | CN¥671.80 Million ≈ $98.31 Million |
+4.19% |
| 2011-12-31 | CN¥644.80 Million ≈ $94.35 Million |
-17.16% |
| 2010-12-31 | CN¥778.34 Million ≈ $113.90 Million |
+24.83% |
| 2009-12-31 | CN¥623.51 Million ≈ $91.24 Million |
+16.65% |
| 2008-12-31 | CN¥534.52 Million ≈ $78.22 Million |
-5.34% |
| 2007-12-31 | CN¥564.66 Million ≈ $82.63 Million |
-20.00% |
| 2006-12-31 | CN¥705.86 Million ≈ $103.29 Million |
+25.09% |
| 2005-12-31 | CN¥564.27 Million ≈ $82.57 Million |
+29.76% |
| 2004-12-31 | CN¥434.85 Million ≈ $63.63 Million |
+39.91% |
| 2003-12-31 | CN¥310.80 Million ≈ $45.48 Million |
+5.97% |
| 2002-12-31 | CN¥293.28 Million ≈ $42.92 Million |
+20.74% |
| 2001-12-31 | CN¥242.90 Million ≈ $35.54 Million |
+17.75% |
| 2000-12-31 | CN¥206.28 Million ≈ $30.19 Million |
+5.97% |
| 1999-12-31 | CN¥194.67 Million ≈ $28.49 Million |
-- |
About Shandong Pharmaceutical Glass Co Ltd
Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more